RB1 and retinoblastoma: Retinoblastoma cells exhibit markers of postmitotic cone precursors and rely on cone-specific signaling components, including the TRβ2, for their proliferation and survival [310], suggesting that the TH signaling pathway may increase susceptibility to the oncogenic effects of RB1 mutations [311].